Indirubin suppresses ovarian cancer cell viabilities through the STAT3 signaling pathway
Lihong Chen, Jinhua Wang, Jianbo Wu, Qiaomei Zheng, Jifen Hu Department of Obstetrics and Gynecology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China Background: Indirubin is the active component of Danggui Longhui Wan, a traditional Chinese medicine formulation. Due to i...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-10-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/indirubin-suppresses-ovarian-cancer-cell-viabilities-through-the-stat3-peer-reviewed-article-DDDT |